Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis (AST-MOMA)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by University Hospital Tuebingen
Information provided by (Responsible Party):
Joerg Henes, University Hospital Tuebingen Identifier:
First received: July 1, 2013
Last updated: October 24, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2020
  Estimated Primary Completion Date: September 2018 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):